Search form

Sections

Valley Fever: Scientists took different routes to find vaccine

Fellowship Story Showcase

Valley Fever: Scientists took different routes to find vaccine

Scientists researching a vaccine for valley fever take different scientific approaches to their work. Some have been stymied by a lack of funding for their work.

Valley Fever: Scientists took different routes to find vaccine
Reporting on Health Collaborative
Saturday, October 6, 2012 - 10:00pm

Five scientists were chosen by a committee affiliated with California State University, Bakersfield, in 1997 to pursue valley fever vaccine research. To reach more about the search for a valley fever vaccine, click here.

Dr. John Galgiani, 66, professor at the University of Arizona and director of the Valley Fever Center for Excellence

  • Developed a vaccine that has been tested in mice and monkeys.
  • Currently working to improve the vaccine to make it cheaper to make.
  • Also working on Nikkomycin Z, a possible valley fever cure.

Dr. Demosthenes Pappagianis, 84, professor and director of the Coccidioidomycosis Serology Laboratoryat the University of California, Davis

  • Began studying the coccidioidesfungus in the early 1950s
  • Currently conducting vaccine tests on mice.
  • Trying to find the right formulation to generate a strong immune response.
  • Also studying how many doses of the vaccine have to be given, and precisely when, in order to get the maximum effect.

Dr. Garry Cole, 71, professor and chair in medical mycologyat the University of Texas at San Antonio

  • Generated a live vaccine that has been tested in mice.
  • Vaccine has been attenuated – meaning weakened – to make it safe for immunizations.
  • Working to modify vaccine to confirm that – once injected – it would not become infectious.
  • Hoping to test the vaccine in primates and, eventually, humans.
  • Developing a second vaccine with a different formulation.

Dr. Rebecca Cox, 62, scientist at the University of Texas Health Science Center at San Antonio.

  • Studied the coccidioidesfungus for 30 years.
  • Focused on the role of the human immune system in combating the fungus once it was inhaled.
  • Died July 14, 2006.

Dr. Theo Kirkland, 62, professor of pathology and medicine at the University of California, San Diego.

  • Tested a vaccine in mice but wasn’t able to pursue it further.
  • Stopped doing research on valley fever after funding for his project ran out.

Related Stories:

Valley Fever Vaccine Stalls

Just One Breath: Valley fever cases reach epidemic levels, but harm remains hidden 

Valley Fever Costs Mount for Patients and Taxpayers

Taxpayers spend millions on valley fever in prisons

Just One Breath: Five Tips for Writing about Health Costs

About This Series

This project results from a new venture – the Reporting On Health collaborative – which involves the Bakersfield Californian, the Merced Sun-Star, Radio Bilingüe in Fresno, The Record in Stockton, Valley Public Radio in Fresno and Bakersfield, Vida en el Valle in Fresno, the Voice of OC in Santa Ana and ReportingonHealth.org. The collaborative is an initiative of The California Endowment Health Journalism Fellowships at the University of Southern California’s Annenberg School for Communication and Journalism.

RELATED STORIES THIS WEEK

Reported valley fever cases fell in California, Arizona last year

California’s tally of valley fever cases dropped by more than 1,000 last year and some counties have also seen fewer cases in the early months of 2013. But public health officials say it’s too early to identify long-term trends in the numbers.

State Raises Questions About Moving Inmates At Risk of Valley Fever

California's Attorney General has questioned the feasibility of the federal order to move more than 3,000 inmates especially vulnerable to valley fever from two Central Valley prisons.

State Prison Officials: Receiver's Valley Fever Policy 'Premature'

Officials say they need "further clarification" before they can implement an order from the federal receiver in charge of California's prison system that requires inmates vulnerable to valley fever be moved from Central Valley prisons.

Prison Health Advocates Call For More Steps to Stop Valley Fever Outbreak

State and experts are now digesting the directive for California's Department of Corrections to remove inmates from two Central Valley prisons, who are especially at risk of contracting valley fever.

Experts hail step to move at-risk inmates out of valley fever hot spots

Still, moving thousands of prisoners is a massive endeavor complicated by factors such as inmates’ security levels, and medical, mental health and rehabilitation needs.